Perspective on the use of sulfated polysaccharides from marine organisms as a source of new antithrombotic drugs

Marine Drugs

Volumn 13, Issue 5, 2015, Pages 2770-2784

  Mourão, Paulo A S ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Anticoagulant drugs; Carrageenans; Fucoidan; Fucosylated chondroitin sulfate; Glycosaminoglycan like polysaccharides; Sulfated fucans; Sulfated galactans

Indexed keywords

ANTICOAGULANT AGENT; CARRAGEENAN; FUCOIDIN; HEPARIN; HEPARIN DERIVATIVE; POLYSACCHARIDE SULFATE; PROTAMINE; SERINE PROTEINASE INHIBITOR; FIBRINOLYTIC AGENT; POLYSACCHARIDE; SULFATE;

ADVERSE OUTCOME; ANTICOAGULANT THERAPY; ANTICOAGULATION; BLOOD CLOTTING; BROWN ALGA; DRUG ISOLATION; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; EMBOLISM PREVENTION; EXPERIMENTAL THROMBOSIS; HYPOTENSION; IN VITRO STUDY; MARINE SPECIES; MOLECULAR WEIGHT; NONHUMAN; PROTEIN INTERACTION; RED ALGA; REVIEW; STEREOSPECIFICITY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; THROMBOSIS PREVENTION; ANIMAL; AQUATIC SPECIES; CHEMISTRY; HUMAN; THROMBOEMBOLISM;

ANIMALIA;

ANIMALS; AQUATIC ORGANISMS; FIBRINOLYTIC AGENTS; HUMANS; POLYSACCHARIDES; SULFATES; THROMBOEMBOLISM;

EID: 84930648791     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md13052770     Document Type: Review

References (49)

1. Norma, R. 100 years. Looking back. Skill, drive and luck: The discovery and development of heparin. CMAJ 2011, 13, 2139-2140.
2. Mulloy, B.; Gray, E.; Barrowcliffe, T.W. Characterization of unfractionated heparin: Comparison of materials from the last 50 years. Thromb. Haemost. 2000, 84, 1052-1056.
3. Tagarakis, G.; Tsilimingas, N.B. Heparin-coated extracorporeal circulation systems in heart surgery. Recent Pat. Cardiovasc. Drug Discov. 2009, 4, 177-179.
4. Molitor, B.; Klingel, R.; Hafner, G. Monitoring of the heparin therapy during acute haemodialysis. Hamostaseologie 2005, 25, 272-278.
5. Alban, S. Adverse Effects of Heparin. Handb. Exp. Pharmacol. 2012, 207, 211-264.
6. Introduction of Proposal for Reintroduction of Bovine Heparin to the U.S. Market. Available online: http://www.fda.gov/downloads/UCM399418.pdf (accessed on 4 March 2015).
7. Aquino, R.S.; Pereira, M.S.; Vairo, B.C.; Cinelli, L.P.; Santos, G.R.C.; Fonseca, R.J.C.; Mourão, P.A.S. Heparins from porcine and bovine intestinal mucosa: Are they similar drugs? Thromb. Haemost. 2010, 103, 1005-1015.
8. Chemaly, R.F.; Rathod, D.B.; Sikka, M.K.; Hayden, M.K.; Hutchins, M.; Tracy Horn, T.; Jeffery Tarrand, J.; Javier Adachi, J.; Kim Nguyen, K.; Trenholme, G.; et al. Serratia marcescens bacteremia because of contaminated prefilled heparin and saline syringes: A multi-state report. Am. J. Infect. Control 2011, 39, 521-524.
9. Kishimoto, T.K.; Viswanathan, K.; Ganguly, T.; Elankumaran, S.; Smith, S.; Pelzer, K.; Lansing, J.C.; Sriranganathan, N.; Zhao, G.; Galcheva-Gargova, Z.; et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. N. Engl. J. Med. 2008, 358, 2457-2467.
10. Guerrini, M.; Beccati, D.; Shriver, Z.; Naggi, A.; Viswanathan, K.; Bisio, A.; Capila, I.; Lansing, J.C.; Guglieri, S.; Fraser, B.; et al. Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat. Biotechnol. 2008, 26, 669-675.
11. Melo, E.I.; Pereira, M.S.; Cunha, R.S.; Sá, M.P.; Mourão, P.A.S. Heparin quality control in the Brazilian market: Implications in the cardiovascular surgery. Rev. Bras. Cir. Cardiovasc. 2008, 23, 169-174.
12. Mourão, P.A.S. Use of sulfated fucans as anticoagulant and antithrombotic agents: Future perspectives. Curr. Pharm. Des. 2004, 10, 967-981.
13. Pomin, V.H.; Mourão, P.A.S. Structure, biology, evolution, and medical importance of sulfated fucans and galactans. Glycobiology 2008, 18, 1016-1027.
14. Mourão, P.A.S. A carbohydrate-based mechanism of species recognition in sea urchin fertilization. Braz. J. Med. Biol. Res. 2007, 40, 5-17.
15. Usov, A.I. Structural analysis of red seaweed galactans of agar and carrageenan groups. Food Hydrocoll. 1998, 12, 301-308.
16. Farias, W.R.; Valente, A.P.; Pereira, M.S.; Mourão, P.A.S. Structure and anticoagulant activity of sulfated galactans. Isolation of a unique sulfated galactan from the red algae Botryocladia occidentalis and comparison of its anticoagulant action with that of sulfated galactans from invertebrates. J. Biol. Chem. 2000, 275, 29299-29307.
17. Lahaye, M. Developments on gelling algal galactans, their structure and physico-chemistry. J. Appl. Phycol. 2001, 13, 173-184.
18. Pereira, M.G.; Benevides, N.M.; Melo, M.R.; Valente, A.P.; Melo, F.R.; Mourão, P.A.S. Structure and anticoagulant activity of a sulfated galactan from the red alga, Gelidium crinale. Is there a specific structural requirement for the anticoagulant action? Carbohydr. Res. 2005, 340, 2015-2023.
19. Quinderé, A.L.G.; Santos, G.R.C.; Oliveira, S.N.M.C.G.; Glauser, B.F.; Fontes, B.F.; Queiroz, I.N.L.; Benevides, N.M.B.; Pomin, V.H.; Mourão, P.A.S. Is the antithrombotic effect of sulfated galactans independent of serpin? J. Thromb. Haemost. 2014, 12, 43-53.
20. Alves, A.P.; Mulloy, B.; Diniz, J.A.; Mourão, P.A.S. Sulfated polysaccharides from the egg jelly layer are species-specific inducers of acrosomal reaction in sperms of sea urchins. J. Biol. Chem. 1997, 272, 6965-6971.
21. Castro, M.O.; Pomin, V.H.; Santos, L.L.; Vilela-Silva, A.C.E.S.; Hirohashi, N.; Pol-Fachin, L.; Verli, H.; Mourão, P.A.S. A unique 2-sulfated β-galactan from the egg jelly of the sea urchin Glyptocidaris crenularis: Conformational flexibily versus induction of the sperm acrosome reaction. J. Biol. Chem. 2009, 284, 18790-18800.
22. Chevolot, L.; Foucault, A.; Kervarec, N.; Sinquin, C.; Fisher, A.M.; Boisson-Vidal, C. Further data on the structure of brown seaweed fucans: Relationships with anticoagulant activity. Carbohydr. Res. 1999, 319, 154-165.
23. Chevolot, L.; Mulloy, B.; Ratiskol, J.; Foucault, A.; Colliec-Jouault, S. A disaccharide repeat unit is the major structure in fucoidans from two species of brown algae. Carbohydr. Res. 2000, 330, 529-535.
24. Bilan, M.I.; Grachev, A.A.; Ustuzhanina, N.E.; Shashkov, A.S.; Nifantiev, N.E.; Usov, A.I. Structure of a fucoidan from the brown seaweed Fucus evanescens. Carbohydr. Res. 2002, 337, 719-730.
25. Vilela-Silva, A.C.E.S.; Alves, A.P.; Valente, A.P.; Vacquier, V.D.; Mourão, P.A.S. Structure of the sulfated α-L-fucan from the egg jelly coat of the sea urchin Strongylocentrotus franciscanus: Patterns of preferential 2-O- and 4-O-sulfation determine sperm cell recognition. Glycobiology 1999, 9, 225-232.
26. Vilela-Silva, A.C.E.S.; Castro, M.O.; Valente, A.P.; Biermann, C.H.; Mourão, P.A.S. Sulfated fucans from the egg jellies of the closely related sea urchins Strongylocentrotus droebachiensis and Strongylocentrotus pallidus ensure species specific fertilization. J. Biol. Chem. 2002, 277, 379-387.
27. Soeda, S.; Ohmagari, Y.; Shimeno, H.; Nagamatsu, A. Preparation of oversulfated fucoidans fragments and evaluation of their antithrombotic activities. Thromb. Res. 1993, 72, 247-256.
28. Haroun-Bouhedja, F.; Ellouali, M.; Sinquin, C.; Boisson-Vidal, C. Relationship between sulfate groups and biological activities of fucans. Thromb. Res. 2000, 100, 453-458.
29. Gray, E.; Hogwood, J.; Mulloy, B. The anticoagulant and antithrombotic mechanisms of heparin. Handb. Exp. Pharmacol. 2012, 207, 347-360.
30. Melo, F.R.; Pereira, M.S.; Foguel, D.; Mourão, P.A.S. Antithrombin-mediated anticoagulant activity of sulfated polysaccharides: Different mechanisms for heparin and sulfated galactans. J. Biol. Chem. 2004, 279, 20824-20835.
31. Fonseca, R.J.C.; Oliveira, S.N.M.C.G.; Pomin, V.H.; Mecawi, A.S.; Iracema, G.; Araujo, I.G.; Mourão, P.A.S. Effects of oversulfated and fucosylated chondroitin sulfates on coagulation, Challenges for the study of anticoagulant polysaccharides. Thromb. Haematol. 2010, 103, 994-1004.
32. Pereira, M.S.; Melo, F.R.; Mourão, P.A.S. Is there a correlation between structure and anticoagulant action of sulfated galactans and sulfated fucans? Glycobiology 2002, 12, 573-580.
33. Mourão, P.A.S.; Pereira, M.S.; Pavão, M.S.G.; Mulloy, B.; Tollefsen, D.M.; Mowinckel, M.C.; Abildgaard, U. Structure and anticoagulant activity of a fucosylated chondroitin sulfate from echinoderm: Sulfated fucose branches on the polysaccharide account for its high anticoagulant activity, J. Biol. Chem. 1996, 271, 23973-23984.
34. Ribeiro, A.C.; Vieira, R.P.; Mourão, P.A.S.; Mulloy, B. A sulfated α-L-fucan from sea cucumber. Carbohydr. Res. 1994, 255, 225-240.
35. Fonseca, R.J.C.; Santos, G.R.C.; Mourão, P.A.S. Effects of polysaccharides enriched in 2,4-disulfated fucose units on coagulation, thrombosis and bleeding. Practical and conceptual implications. Thromb. Haematol. 2009, 102, 829-836.
36. Pereira, M.S.; Vilela-Silva, A.C.E.S.; Valente, A.P.; Mourão, P.A.S. A 2-sulfated, 3-linked α-L-galactan is an anticoagulante polysaccharide. Carbohydr. Res. 2002, 337, 2231-2238.
37. Glauser, B.F.; Pereira, M.S.; Monteiro, R.Q.; Mourão, P.A.S. Serpin-independent anticoagulant activity of a fucosylated chondroitin sulfate. Thromb. Haemost. 2008, 100, 420-428.
38. Glauser, B.F.; Rezende, R.M.; Melo, F.R.; Pereira, M.S.; Francischetti, I.M.B.; Monteiro, R.Q.; Rezaie, A.R.; Mourão, P.A.S. Anticoagulant activity of a sulfated galactan: Serpin-independent effect and specific interaction with factor Xa. Thromb. Haemost. 2009, 102, 1183-1193.
39. Melo, F.R.; Mourão, P.A.S. Sulfated galactan has an unusual effect on thrombosis due to activation of factor XII and inhibition of the coagulation proteases. Thromb. Haemost. 2008, 99, 531-538.
40. Liu, T.; Scallan, C.D.; Broze, G.J., Jr.; Patarroyo-White, S.; Pierce, G.F.; Johnson, K.W. Improved coagulation in bleeding disorders by non-anticoagulant sulfated polysaccharides (NASP). Thromb. Haemostas. 2006, 95, 68-76.
41. Zhang, Z.; Till, S.; Jiang, C.; Knappe, S.; Reutterer, S.; Scheiflinger, F.; Szabo, C.M.; Dockal, M. Structure-activity relationship of the pro- and anticoagulant effects of Fucus vesiculosus fucoidan. Thromb. Haemost. 2014, 111, 429-437.
42. Farias, W.F.; Nazareth, R.A.; Mourão, P.A.S. Dual effects of sulfated D-galactans from the red algae Botryocladia occidentalis preventing thrombosis and inducing platelet aggregation. Thromb. Haemost. 2001, 86, 1540-1546.
43. Holster, I.L.; Valkhoff, V.E.; Kuipers, E.J.; Tjwa, E.T. New oral anticoagulants increase risk for gastrointestinal bleeding: A systematic review and meta-analysis. Gastroenterology 2013, 145, 105-112.
44. Holster, I.L.; Hunfeld, N.G.; Kuipers, E.J.; Kruip, M.J.; Tjwa, E.T. On the treatment of new oral anticoagulant-associated gastrointestinal hemorrhage. J. Gastrointestin. Liver Dis. 2013, 22, 229-231.
45. Fitton, J.H. Therapies from fucoidan; multifunctional marine polymers. Mar. Drugs 2011, 9, 1731-1760.
46. Michel, C.; Lahaye, M.; Bonnet, C.; Mabeau, S.; Barry, J.L. In vitro fermentation by human fecal bacteria of total and purified dietary fibers from brown seaweeds. Br. J. Nutr. 1996, 75, 263-280.
47. Yamada, Y.; Miyoshi, T.; Tanada, S.; Imaki, M. Digestibility and energy availability of Wakame (Undaria pinnatifida) seaweed in Japanese. Nippon Eiseigaku Zasshi 1991, 46, 788-794.
48. Fonseca, R.J.C.; Mourão, P.A.S. Fucosylated chondroitin sulfate as a new oral antithrombotic agent. Thromb. Haemost. 2006, 96, 822-829.
49. Nagamine, T.; Nakazato, K.; Tomioka, S.; Iha, M.; Nakajima, K. Intestinal absorption of fucoidan extracted from the brown seaweed, Cladosiphono kamuranus. Mar. Drugs 2015, 13, 48-64.